8-K current report · filed Oct 15, 2026

SUPERNUS PHARMACEUTICALS, INC. (SUPN) 8-K Current Report: October 15, 2026

Item 5.07SUPN overview

Short answer

SUPERNUS PHARMACEUTICALS, INC. (SUPN) filed an 8-K current report with the SEC on October 15, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Merger approved: 48,249,532 votes for versus 235,601 against.

SUPERNUS PHARMACEUTICALS, INC. 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.07 · Submission of Matters to a Vote of Security Holders

  • Merger approved: 48,249,532 votes for versus 235,601 against
  • Supernus becomes a wholly owned Indivior subsidiary after Merger Sub merger completion
  • Executive merger compensation approved on advisory basis: 32,688,410 for versus 15,847,350 against
  • Shareholder vote based on 58,224,143 shares outstanding as of September 4, 2026

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other SUPERNUS PHARMACEUTICALS, INC. 8-K filings

Get the next SUPN 8-K as it lands

Follow SUPN for push alerts, or ask the research agent what this filing means.